Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024

Rhea-AI Summary

Agile Therapeutics, Inc. (AGRX) will announce its fourth quarter and full year 2023 financial results on March 22, 2024. The company will host a live conference call and webcast at 8:30 a.m. ET to discuss the financial results and provide a business update.

Live Conference Call and Webcast at 8:30 a.m. ET

PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before the market opens on Friday, March 22, 2024. Following the release, the Company will host a live conference call and webcast at 8:30 a.m. ET to discuss the Company’s financial results and provide a business update.

Event	Agile Therapeutics Fourth Quarter & Full Year 2023 Financial Results Conference Call
Date	Friday, March 22, 2024
Time	8:30 a.m. ET / 5:30 a.m. PT

A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call.

About Agile Therapeutics, Inc.

Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla^®, (levonorgestrel and ethinyl estradiol) transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion^®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website and LinkedIn account.

FAQ

When will Agile Therapeutics (AGRX) report its fourth quarter and full year 2023 financial results?

Agile Therapeutics (AGRX) will report its fourth quarter and full year 2023 financial results on Friday, March 22, 2024.

What time will the live conference call and webcast take place for Agile Therapeutics (AGRX) fourth quarter & full year 2023 financial results?

The live conference call and webcast for Agile Therapeutics (AGRX) fourth quarter & full year 2023 financial results will take place at 8:30 a.m. ET on March 22, 2024.

How can I access the live webcast of the conference call for Agile Therapeutics (AGRX) fourth quarter & full year 2023 financial results?

You can access the live webcast of the conference call for Agile Therapeutics (AGRX) fourth quarter & full year 2023 financial results via the Investor Relations portion of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations.

How can I participate in the live conference call via telephone for Agile Therapeutics (AGRX) fourth quarter & full year 2023 financial results?

To participate in the live conference call via telephone for Agile Therapeutics (AGRX) fourth quarter & full year 2023 financial results, please register on the provided link. Upon registering, you will receive a dial-in number and unique PIN to join the conference call.